TY - JOUR
T1 - Meta-analysis of transcriptional regulatory networks for lipid metabolism in neural cells from schizophrenia patients based on an open-source intelligence approach
AU - Okamoto, Lisa
AU - Watanabe, Soyoka
AU - Deno, Senka
AU - Nie, Xiang
AU - Maruyama, Junichi
AU - Tomita, Masaru
AU - Hatano, Atsushi
AU - Yugi, Katsuyuki
N1 - Funding Information:
This work is supported by funding from JSPS KAKENHI grants JP15H05582 , JP18H05431 and “ Creation of Innovative Technology for Medical Applications Based on the Global Analyses and Regulation of Disease-Related Metabolites ”, PRESTO ( JPMJPR1538) from JST . L.O. and S.D. were supported by research funds from the Yamagata prefectural government and the City of Tsuruoka . A.H. was supported by a Grant‐in‐Aid for Scientific Research on Innovative Areas “Transomic Analysis of Metabolic Adaptation” ( JP17H06300) from JSPS KAKENHI. X.N. is supported by a JSPS KAKENHI grant JP21J01116. L.O., A.H. and K.Y. conceived the project. L.O. reconstructed differentially regulated networks and S.D. visualized and analyzed the reconstructed networks. S.W. performed identification of DEGs from the transcriptome data, integration of GTEx eQTL data with the reconstructed networks and enrichment analysis of the SNPs associated with the DEGs. X.N. conducted bibliometric analysis based on the enriched EFO terms. J.M. compiled the data processing pipeline. L.O., S.W., S.D., X.N., J.M., M.T., A.H., and K.Y. wrote the manuscript.
Publisher Copyright:
© 2022 The Authors
PY - 2022/2
Y1 - 2022/2
N2 - There have been a number of reports about the transcriptional regulatory networks in schizophrenia. However, most of these studies were based on a specific transcription factor or a single dataset, an approach that is inadequate to understand the diverse etiology and underlying common characteristics of schizophrenia. Here we reconstructed and compared the transcriptional regulatory network for lipid metabolism enzymes using 15 public transcriptome datasets of neural cells from schizophrenia patients. Since many of the well-known schizophrenia-related SNPs are in enhancers, we reconstructed a network including enhancer-dependent regulation and found that 53.3 % of the total number of edges (7,577 pairs) involved regulation via enhancers. By examining multiple datasets, we found common and unique transcriptional modes of regulation. Furthermore, enrichment analysis of SNPs that were connected with genes in the transcriptional regulatory networks by eQTL suggested an association with hematological cell counts and some other traits/diseases, whose relationship to schizophrenia was either not or insufficiently reported in previous studies. Based on these results, we suggest that in future studies on schizophrenia, information on genotype, comorbidities and hematological cell counts should be included, along with the transcriptome, for a more detailed genetic stratification and mechanistic exploration of schizophrenia.
AB - There have been a number of reports about the transcriptional regulatory networks in schizophrenia. However, most of these studies were based on a specific transcription factor or a single dataset, an approach that is inadequate to understand the diverse etiology and underlying common characteristics of schizophrenia. Here we reconstructed and compared the transcriptional regulatory network for lipid metabolism enzymes using 15 public transcriptome datasets of neural cells from schizophrenia patients. Since many of the well-known schizophrenia-related SNPs are in enhancers, we reconstructed a network including enhancer-dependent regulation and found that 53.3 % of the total number of edges (7,577 pairs) involved regulation via enhancers. By examining multiple datasets, we found common and unique transcriptional modes of regulation. Furthermore, enrichment analysis of SNPs that were connected with genes in the transcriptional regulatory networks by eQTL suggested an association with hematological cell counts and some other traits/diseases, whose relationship to schizophrenia was either not or insufficiently reported in previous studies. Based on these results, we suggest that in future studies on schizophrenia, information on genotype, comorbidities and hematological cell counts should be included, along with the transcriptome, for a more detailed genetic stratification and mechanistic exploration of schizophrenia.
KW - Enhancer
KW - Lipid metabolism
KW - Meta-analysis
KW - Open-source intelligence
KW - Schizophrenia
KW - Transcriptional regulatory network
UR - http://www.scopus.com/inward/record.url?scp=85123114072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123114072&partnerID=8YFLogxK
U2 - 10.1016/j.neures.2021.12.006
DO - 10.1016/j.neures.2021.12.006
M3 - Article
C2 - 34979163
AN - SCOPUS:85123114072
SN - 0168-0102
VL - 175
SP - 82
EP - 97
JO - Neuroscience Research
JF - Neuroscience Research
ER -